Saing, John Crisler Jay B.
HRN: 28-21-88 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2025
CEFTRIAXONE 1G (VIAL)
12/06/2025
12/13/2025
IV
2g
Q24 Anst
Open Fracture
Checking Final Appropriateness
12/12/2025
CO-AMOXICLAV 625MG (TAB)
12/12/2025
12/18/2025
IV
625mg
Q8
Open Patellar Fracture Post Op
Checking Final Appropriateness